Eptifibatide
Product Name:Eptifibatide
CAS:188627-80-7
MF:C35H49N11O9S2
MW:831.96
Usage:A Arginin-glycin-aspartat-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events.
Â
Appearance | White crystalline powder |
Package | 1g/aluminium foil bag or as required |
Usage | can be used as weightloss |
Minimum order quantity | 1g |
passment | Professional team special for package and shipment and staring |
 | on tracking code 24hours for customs pass guaranteed |
Shipping | By express courier |
Shipping leading time | Within 24 hours after receiving the payment |
Payment options | Western Union, MoneyGram, T/T,Bank transfer |
shipping | 1)Express delivery with DHL,EMS,FedEx,HKEMS,TNT,UPS |
 | (Express delivery within 24 hours after payment) |
 | 2)By sea (large quantity ,it will take 30-45days) |
Price | Negotiated |
Supply ability | 50g/Month |
Brief introduction:
Â
Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.[1] Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the so-called arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.
Â
Indications
Â
Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevation (e.g., non-Q-wave) myocardial infarction (I.e., non-ST-segment elevation acute coronary syndromes) both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary intervention (PCI).
Â
The drug is usually applied together with aspirin or clopidogrel and (low molecular weight or unfractionated) heparin. Additionally, the usual supportive treatment consisting of applications of nitrates, beta-blockers, opioid analgesics and/or benzodiazepines should be employed as indicated. Angiographic evaluation and other intensive diagnostic procedures may be considered a first line task before initiating therapy with eptifibatide.
Â
The drug should exclusively be used in hospitalized patients both because of the serious degree of patients' illness and because of the possible side-effects of eptifibatide.
Â
Contraindications and precautions
Â
Thrombocytopenia : The drug is contraindicated in patients with platelet counts of less than 100,000 per μl because no clinical experience exists regarding such patients.
Renal insufficiency : Eptifibatide undergoes renal elimination. In such patients with renal insufficiency where a glycoprotein IIb/IIIa inhibitor is likely to provide benefit, Abciximab (trade name: Reopro) is an alternative medication.
Current bleeding tendencies or abnormally prolonged coagulation parameters observed within 30 days before starting therapy with eptifibatide is intended.
Coagulation parameters such as ACT, aPTT, TT, and PT should be followed closely during therapy and afterwards.
Allergy to eptifibatide and/or other ingredients.
Severe, uncontrolled hypertension.
Pregnancy :Â No experience exists. Pregnant patients should be treated only when clearly needed.
Lactation :Â No human data exists. Breast-feeding should be avoided during treatment in order to prevent damage to the newborn.
Geriatric patients :Â No differences in side effects compared with younger patients have been seen. Nevertheless, geriatric patients should be very closely observed for bleeding and other side-effects.
Pediatric patients :Â Eptifibatide is not indicated in patients below 18 years of age, because no experience exists
Product Image

More products:
CAS | NAME |
137-58-6 Â Â | Lidocaine |
73-78-9 | Lidocaine Hydrochloride |
51-05-8 | Procaine Hydrochloride |
614-39-1 Â | Procainamide Hydrochloride |
94-09-7 Â Â Â | Benzocaine |
59-46-1 | Procaine |
94-24-6 Â Â Â | Tetracaine |
1786-81-8 Â | Propitocaine Hydrochloride |
637-58-1 Â | Pramoxine Hydrochloride |
721-50-6 | Prilocaine |
14252-80-3 Â Â Â | Levobupivacaine Hydrochloride |
23964-57-0 | Articaine Hydrochloride |
2180-92-9 | Bupivacaine |
136-47-0 | Tetracaine Hydrochloride |
98717-15-8 | Ropivacaine Hydrochloride |
1722-62-9 | Carbocaine Hydrochloride |
22801-44-1 Â Â | Mepivacaine Base |
1027-14-1 Â | Trimecaine |
85-79-0 | Dibucaine |
854056-07-8 | Ropivacaine Mesylate |
27262-47-1 Â Â | Levobupivacaine |
553-63-9 | Larocaine HCl |
94-15-5 Â | DimethoCaine |
5875-06-9 | Proparacaine Hydrochloride |
5987-82-6 | Oxybuprocaine Hydrochloride |

Factory PhotoÂ

                               COA
ITEMS | SPECIFICATION | TESTRESULTS |
Appearance | Off-white or white powder | Conforms |
Identification | HPLC,NMR;LC-MS | Conforms |
Related substances | Individual impurity≤0.5% | 0.09% |
Total impurities≤1.0% | 0.20% | |
Loss on drying | ≤0.5% | 0.3% |
Residue on ignition | ≤0.1% | 0.04% |
Heavy metals | ≤10ppm | Conforms |
Assay | ≥98.0 % | 99.1% |
1. We have experience in exporting steroids, as you know, EU places much emphasis on them, and you must find a experienced partner who will assure you;Â
2. Quality: Our company is a professional leading factory in China in pharmaceutical area, We had stable customers and exported to Germany, Spain, UK, USA, Australia, Middle East, and any other countries. We can provide good references about our company. As for the quality of the products, we 're sure they can satisfy you well enough;Â
3. Package: Professional packing with professional materialsÂ
4. Delivery: We have products in stock, and we will deliver them soon when your PO arrived. Meanwhile we will give you the tracking number in order to make you know the exact location of the products. We will keep track of the product until they arrive you; We choose the best courier service for you, and with the delivery around 5-7 working days.Â
5. Service: Best Service with after-sales service and consultation

If you want to know more about our products,please search
http://www.slsteroid.com/.
Product DetailsEptifibatide
Product Name:Eptifibatide
CAS:188627-80-7
MF:C35H49N11O9S2
MW:831.96
Usage:A Arginin-glycin-aspartat-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events.
Â
Appearance | White crystalline powder |
Package | 1g/aluminium foil bag or as required |
Usage | can be used as weightloss |
Minimum order quantity | 1g |
passment | Professional team special for package and shipment and staring |
 | on tracking code 24hours for customs pass guaranteed |
Shipping | By express courier |
Shipping leading time | Within 24 hours after receiving the payment |
Payment options | Western Union, MoneyGram, T/T,Bank transfer |
shipping | 1)Express delivery with DHL,EMS,FedEx,HKEMS,TNT,UPS |
 | (Express delivery within 24 hours after payment) |
 | 2)By sea (large quantity ,it will take 30-45days) |
Price | Negotiated |
Supply ability | 50g/Month |
Brief introduction:
Â
Eptifibatide (Integrilin, Millennium Pharmaceuticals, also co-promoted by Schering-Plough/Essex), is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class.[1] Eptifibatide is a cyclic heptapeptide derived from a protein found in the venom of the southeastern pygmy rattlesnake (Sistrurus miliarius barbouri). It belongs to the class of the so-called arginin-glycin-aspartat-mimetics and reversibly binds to platelets. Eptifibatide has a short half-life. The drug is the third inhibitor of GPIIb/IIIa that has found broad acceptance after the specific antibody abciximab and the non-peptide tirofiban entered the global market.
Â
Indications
Â
Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevation (e.g., non-Q-wave) myocardial infarction (I.e., non-ST-segment elevation acute coronary syndromes) both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary intervention (PCI).
Â
The drug is usually applied together with aspirin or clopidogrel and (low molecular weight or unfractionated) heparin. Additionally, the usual supportive treatment consisting of applications of nitrates, beta-blockers, opioid analgesics and/or benzodiazepines should be employed as indicated. Angiographic evaluation and other intensive diagnostic procedures may be considered a first line task before initiating therapy with eptifibatide.
Â
The drug should exclusively be used in hospitalized patients both because of the serious degree of patients' illness and because of the possible side-effects of eptifibatide.
Â
Contraindications and precautions
Â
Thrombocytopenia : The drug is contraindicated in patients with platelet counts of less than 100,000 per μl because no clinical experience exists regarding such patients.
Renal insufficiency : Eptifibatide undergoes renal elimination. In such patients with renal insufficiency where a glycoprotein IIb/IIIa inhibitor is likely to provide benefit, Abciximab (trade name: Reopro) is an alternative medication.
Current bleeding tendencies or abnormally prolonged coagulation parameters observed within 30 days before starting therapy with eptifibatide is intended.
Coagulation parameters such as ACT, aPTT, TT, and PT should be followed closely during therapy and afterwards.
Allergy to eptifibatide and/or other ingredients.
Severe, uncontrolled hypertension.
Pregnancy :Â No experience exists. Pregnant patients should be treated only when clearly needed.
Lactation :Â No human data exists. Breast-feeding should be avoided during treatment in order to prevent damage to the newborn.
Geriatric patients :Â No differences in side effects compared with younger patients have been seen. Nevertheless, geriatric patients should be very closely observed for bleeding and other side-effects.
Pediatric patients :Â Eptifibatide is not indicated in patients below 18 years of age, because no experience exists
Product Image

More products:
CAS | NAME |
137-58-6 Â Â | Lidocaine |
73-78-9 | Lidocaine Hydrochloride |
51-05-8 | Procaine Hydrochloride |
614-39-1 Â | Procainamide Hydrochloride |
94-09-7 Â Â Â | Benzocaine |
59-46-1 | Procaine |
94-24-6 Â Â Â | Tetracaine |
1786-81-8 Â | Propitocaine Hydrochloride |
637-58-1 Â | Pramoxine Hydrochloride |
721-50-6 | Prilocaine |
14252-80-3 Â Â Â | Levobupivacaine Hydrochloride |
23964-57-0 | Articaine Hydrochloride |
2180-92-9 | Bupivacaine |
136-47-0 | Tetracaine Hydrochloride |
98717-15-8 | Ropivacaine Hydrochloride |
1722-62-9 | Carbocaine Hydrochloride |
22801-44-1 Â Â | Mepivacaine Base |
1027-14-1 Â | Trimecaine |
85-79-0 | Dibucaine |
854056-07-8 | Ropivacaine Mesylate |
27262-47-1 Â Â | Levobupivacaine |
553-63-9 | Larocaine HCl |
94-15-5 Â | DimethoCaine |
5875-06-9 | Proparacaine Hydrochloride |
5987-82-6 | Oxybuprocaine Hydrochloride |

Factory PhotoÂ

                               COA
ITEMS | SPECIFICATION | TESTRESULTS |
Appearance | Off-white or white powder | Conforms |
Identification | HPLC,NMR;LC-MS | Conforms |
Related substances | Individual impurity≤0.5% | 0.09% |
Total impurities≤1.0% | 0.20% | |
Loss on drying | ≤0.5% | 0.3% |
Residue on ignition | ≤0.1% | 0.04% |
Heavy metals | ≤10ppm | Conforms |
Assay | ≥98.0 % | 99.1% |
1. We have experience in exporting steroids, as you know, EU places much emphasis on them, and you must find a experienced partner who will assure you;Â
2. Quality: Our company is a professional leading factory in China in pharmaceutical area, We had stable customers and exported to Germany, Spain, UK, USA, Australia, Middle East, and any other countries. We can provide good references about our company. As for the quality of the products, we 're sure they can satisfy you well enough;Â
3. Package: Professional packing with professional materialsÂ
4. Delivery: We have products in stock, and we will deliver them soon when your PO arrived. Meanwhile we will give you the tracking number in order to make you know the exact location of the products. We will keep track of the product until they arrive you; We choose the best courier service for you, and with the delivery around 5-7 working days.Â
5. Service: Best Service with after-sales service and consultation

If you want to know more about our products,please search
http://www.slsteroid.com/.
Medical Cold Patch
Throat Pain Relief Patch
[Name] Medical Cold Patch
[Package Dimension] 36 round pieces
The pain relief patch is composed of three layers, namely, backing lining, middle gel and protective film. It is free from pharmacological, immunological or metabolic ingredients.
[Scope of Application] For cold physiotherapy, closed soft tissue only.
[Indications]
The patches give fast acting pain relief for acute and chronic tonsillitis.
[How To Use a Patch]
Please follow the Schematic Diagram. One piece, one time.
The curing effect of each piece can last for 6-8 hours.
[Attention]
Do not apply the patch on the problematic skin, such as wounds, eczema, dermatitis,or in the eyes. People allergic to herbs and the pregnant are advised not to use the medication. If swelling or irritation occurs, please stop using and if any of these effects persist or worsen.notify your doctor or pharmacist promptly. Children using the patch must be supervised by adults.
[Storage Conditions] Store below 30c in a dry place away from heat and direct sunlight.
Throat Pain Relief Patch,Throat Pain Relief Pad,Throat Pain Relief Plaster,Antitussive Patch
Shandong XiJieYiTong International Trade Co.,Ltd. , https://www.xjytmedical.com